Our team's research focuses on:

  • The discovery of new targets of interest through "omics" approaches using patient samples
     
  • The study of pathophysiological mechanisms and the "druggability" of these targets
     
  • The development of screening and evaluation methods (biochemical, biophysical, or cellular)
     
  • The discovery of new drug candidates, which we synthesize and optimize in medicinal chemistry programs